The search to painlessly generate induced pluripotent stem cells (iPS cells) is heating up, and Cellular Dynamics International, Inc. is on the leading edge. The USPTO recently published Cellular Dynamics’ patent application for “Generation of Induced Pluripotent Stem Cells from Small Volumes of Peripheral Blood,” which generally discloses methods for increasing the overall process efficiency of reprogramming peripheral blood cells into iPS cells.In a nutshell, pluripotent stem cells can produce any type of cell, whereas tissue stem cells can only produce cells of that tissue type. Embryonic stem cells are pluripotent cells, but as they generally do not exist in…
Read More